Authors:
POSPAI D
CADIOT G
FORESTIER S
RUSZNIEWSKI P
COSTE T
ESCOURROU J
MIGNON M",GRESZE
Citation: D. Pospai et al., EFFICACY AND SAFETY OF LANSOPRAZOLE IN TREATMENT OF ZOLLINGER-ELLISON-SYNDROME. FIRST 6 MONTHS OF FOLLOW-UP, Gastroenterologie clinique et biologique, 22(10), 1998, pp. 801-808
Authors:
CHASSARD D
GUALANO V
FORESTIER S
MILLERIOUX L
JOUBERT M
Citation: D. Chassard et al., EFFECT OF LANSOPRAZOLE (L) ON THE STEADY-STATE PHARMACOKINETICS OF METRONIDAZOLE (M) FOLLOWING CONCOMITANT ADMINISTRATION OF BOTH DRUGS IN 24 HEALTHY-VOLUNTEERS, Gastroenterology, 114(4), 1998, pp. 359-359
Authors:
LAMOULIATTE H
MEGRAUD F
FORESTIER S
LAURENCE M
Citation: H. Lamouliatte et al., COMPARISON OF 2 ONE-WEEK TRIPLE THERAPIES WITH A LOW-DOSE OF LANSOPRAZOLE AND 2 LOW-DOSE ANTIBIOTICS IN HELICOBACTER-PYLORI ERADICATION - AFRENCH STUDY, Gastroenterology, 114(4), 1998, pp. 796-796
Citation: H. Lamouliatte et al., LANSOPRAZOLE (LANSO) 30 MG OR 60 MG COMBINED WITH 2 ANTIBIOTICS [AMOXICILLIN (AMOX) AND CLARITHROMYCIN (CLARI)] TO ERADICATE HELICOBACTER-PYLORI (HPYLORI), Gastroenterology, 114(4), 1998, pp. 798-798
Authors:
LAMOULIATTE H
CAYLA R
ZERBIB F
FORESTIER S
DEMASCAREL A
JOUBERTCOLLIN M
MEGRAUD F
Citation: H. Lamouliatte et al., DUAL THERAPY USING A DOUBLE DOSE OF LANSOPRAZOLE WITH AMOXICILLIN VERSUS TRIPLE THERAPY USING A DOUBLE DOSE OF LANSOPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN TO ERADICATE HELICOBACTER-PYLORI INFECTION - RESULTSOF A PROSPECTIVE RANDOMIZED OPEN STUDY, The American journal of gastroenterology, 93(9), 1998, pp. 1531-1534
Authors:
DIFFEY BL
STOKES RP
FORESTIER S
MAZILIER C
ROUGIER A
Citation: Bl. Diffey et al., SUNCARE PRODUCT PHOTOSTABILITY - A KEY PARAMETER FOR A MORE REALISTICIN-VITRO EFFICACY EVALUATION, EJD. European journal of dermatology, 7(3), 1997, pp. 226-228
Citation: C. Florent et S. Forestier, 24-HOUR MONITORING OF INTRAGASTRIC ACIDITY - COMPARISON BETWEEN LANSOPRAZOLE 30MG AND PANTOPRAZOLE 40MG, European journal of gastroenterology & hepatology, 9(2), 1997, pp. 195-200
Authors:
LAMOULIATTE H
FLORENT C
VICARI F
MEGRAUD F
FORESTIER S
Citation: H. Lamouliatte et al., RECURRENCE OF DUODENAL-ULCERS (DU) DURING 12 MONTHS FOLLOW-UP AFTER CURE OF HELICOBACTER-PYLORI INFECTION, Gut, 41, 1997, pp. 166-167
Authors:
HOUCKE P
FORESTIER S
GOLDFAIN D
GUYOT P
HELBERT T
LAURENT J
REY JF
ROUHIER D
CASSIGNEUL J
MARCHETTI B
PAPAZIAN A
Citation: P. Houcke et al., 15 MG LANSOPRAZOLE DAILY OR 30 MG LANSOPRAZOLE EVERY OTHER DAY IN LONG-TERM TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, Gut, 41, 1997, pp. 202-202
Authors:
HOUCKE P
FORESTIER S
GOLDFAIN D
GUYOT P
HELBERT T
LAURENT J
REY JF
ROUHIER D
CASSIGNEUL J
MARCHETTI B
PAPAZIAN A
Citation: P. Houcke et al., 15 MG LANSOPRAZOLE DAILY OR 30 MG LANSOPRAZOLE EVERY OTHER DAY IN LONG-TERM TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, Gastroenterology, 112(4), 1997, pp. 152-152
Authors:
LAMOULIATTE H
FLORENT C
VICARI F
MEGRAUD F
FORESTIER S
Citation: H. Lamouliatte et al., DUODENAL-ULCER RECURRENCE AFTER HELICOBACTER-PYLORI ERADICATION OR MAINTENANCE THERAPY - A RANDOMIZED, DOUBLE-BLIND-STUDY, Gastroenterology, 112(4), 1997, pp. 193-193
Citation: C. Florent et al., COMPARISON OF THE 24 HOURS INTRAGASTRIC PH PROFILES AFTER 30 MG LANSOPRAZOLE AND 40 MG PANTOPRAZOLE IN HEALTHY-VOLUNTEERS, Gastroenterology, 110(4), 1996, pp. 109-109
Authors:
LAMOULIATTE H
FLORENT C
VICARI F
MEGRAUD F
FORESTIER S
Citation: H. Lamouliatte et al., EFFECT OF LANSOPRAZOLE AND AMOXICILLIN PLUS METRONIDAZOLE ON THE ERADICATION OF HELICOBACTER-PYLORI - A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY, Gastroenterology, 110(4), 1996, pp. 170-170
Authors:
CAYLA R
DEMASCAREL A
ZERBIB F
MEGRAUD F
JOUBERTCOLLIN M
FORESTIER S
LAMOULIATTE H
Citation: R. Cayla et al., HIGH-DOSE OF LANSOPRAZOLE PLUS AMOXICILLIN VERSUS HIGH-DOSE OF LANSOPRAZOLE PLUS AMOXICILLIN AND CLARITHROMYCIN FOR HELICOBACTER-PYLORI (HELICOBACTER-PYLORI) INFECTION, Gastroenterology, 108(4), 1995, pp. 68-68
Authors:
VICARI F
FOLIGUET B
CONROY MC
LOZNIEWSKI A
DENIS JJ
MARCHAL L
WEBER M
JOUBERTCOLLIN M
FORESTIER S
Citation: F. Vicari et al., COMPARATIVE IN-VITRO ACTIVITY OF 8 METAL-SALTS, LANSOPRAZOLE AND CEFOTIAM AGAINST CLINICAL ISOLATES OF HELICOBACTER-PYLORI, Gastroenterology, 108(4), 1995, pp. 936-936
Authors:
PAUL G
RAMDANI A
MIGNON M
VALLOT T
FORESTIER S
CADIOT G
RUSZNIEWSKI P
JOUBERTCOLLIN M
Citation: G. Paul et al., EFFECTS OF LANSOPRAZOLE AND OMEPRAZOLE ON 24-HOUR GASTRIC-ACIDITY ANDBASE-LINE ACID OUTPUT IN 9 PATIENTS WITH ZOLLINGER-ELLISON-SYNDROME, Gastroenterologie clinique et biologique, 18(8-9), 1994, pp. 695-701
Authors:
MIGNON M
HOCHLAF S
FORESTIER S
RUSZNIEWSKI P
VATIER J
JOUBERTCOLLIN M
Citation: M. Mignon et al., ACID INHIBITORY EFFECT OF GRADED DOSES OF LANSOPRAZOLE IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME, Gastroenterologie clinique et biologique, 18(1), 1994, pp. 13-16
Citation: Jf. Bergmann et al., EVOLUTION OF GASTRINEMIA AFTER TREATMENT WITH LANSOPRAZOLE IN DUODENAL-ULCER (DU) AND REFLUX ESOPHAGITIS (RE), Gastroenterology, 104(4), 1993, pp. 42-42
Authors:
DEKORWIN JD
JOUBERT M
BAZIN N
THIAUCOURT D
PROTTE E
GISSLER C
CONROY MC
DUPREZ A
MERLIN P
FORESTIER S
Citation: Jd. Dekorwin et al., LANSOPRAZOLE VERSUS LANSOPRAZOLE PLUS ANTIBIOTICS IN THE TREATMENT OFHELICOBACTER-PYLORI GASTRIC INFECTION, Gastroenterology, 104(4), 1993, pp. 67-67